What is a peptide certificate of analysis (COA)?

A COA is a batch-specific analytical report from a testing laboratory that documents a research peptide's identity, purity, and often net peptide content for a given lot. A complete COA typically pairs an HPLC chromatogram (purity as area percent) with a mass spectrometry spectrum (identity confirmation) plus lot number, sequence, and molecular formula.

How is research peptide purity measured?

Purity is most commonly measured by reverse-phase HPLC, which separates the target peptide from impurities on a C18 column and reports the main peak's area percent relative to total peak area, usually with UV detection at 214 nm. This is complemented by mass spectrometry, which confirms molecular identity rather than purity.

What does '≥99% purity' mean on a peptide COA?

It means that by HPLC area percent, at least 99% of the detectable material is the target peptide, with impurities such as deletion or truncation sequences below 1%. Note that chromatographic purity is distinct from net peptide content, and the detection method defines exactly what the figure captures.

Why is third-party peptide testing important?

Third-party testing means an independent laboratory with no stake in the sale verifies identity and purity, removing the conflict of interest present when a supplier certifies its own product. Look for the testing lab's name, methods, a matching lot number, and raw chromatogram and spectrum images.

Peptide COA, Purity & Third-Party Testing Guide

Q: Are these research peptides for human use?

No. All peptides discussed are supplied strictly for laboratory research use only. They are not for human or veterinary use, are not evaluated or approved by the FDA, and are not intended to diagnose, treat, cure, or prevent any disease.

Peptide COA purity testing is the analytical backbone of credible research-peptide sourcing. A certificate of analysis (COA), supported by high-performance liquid chromatography (HPLC) and mass spectrometry (MS), is what separates a characterized reference material from an unknown white powder. For laboratories running in-vitro and preclinical work, the quality of the input compound directly constrains the quality — and reproducibility — of every downstream result. This hub explains what a COA is, how purity and identity are measured, why third-party verification matters, and how to read the documentation that should accompany any research peptide.

Research Use Only. All peptides and related materials discussed here are supplied strictly for laboratory research use only. They are not for human or veterinary use, are not evaluated or approved by the FDA, and are not intended to diagnose, treat, cure, or prevent any disease. Nothing on this page is medical advice or a dosing protocol. Handling guidance refers to laboratory preparation of research reagents only.

What a Certificate of Analysis (COA) Actually Certifies

A certificate of analysis is a batch-specific analytical report generated by a testing laboratory. It documents that a particular lot of material was assayed and reports the results against defined specifications. A meaningful peptide COA typically contains several distinct data elements, each answering a different scientific question:

Identity — is this molecule what the label claims? Confirmed primarily by mass spectrometry against the theoretical monoisotopic or average mass.
Purity — what fraction of the sample is the target peptide versus impurities? Quantified by HPLC as area percent.
Net peptide content — how much of the vial mass is actual peptide versus counter-ions (e.g., acetate, trifluoroacetate), residual water, and salts.
Physical and batch data — appearance, lot number, molecular formula, sequence, and test date.

Purity and identity are not interchangeable. A sample can be 99% pure by HPLC yet be the wrong sequence entirely; conversely, correct identity by MS says nothing about how much truncated or deletion-sequence contamination is present. Robust characterization requires both, which is why a complete COA pairs an HPLC chromatogram with an MS spectrum. For a line-by-line walkthrough of each field and how to interpret it, see our complete guide to reading a peptide COA.

How Peptide Purity Is Measured: HPLC

Reverse-phase high-performance liquid chromatography (RP-HPLC) is the standard method for quantifying peptide purity. The sample is dissolved and pushed through a hydrophobic C18 column under a gradient of increasing organic solvent (typically acetonitrile with a trifluoroacetic acid or formic acid modifier). Molecules elute at different times based on hydrophobicity, and a UV detector — usually monitoring at 214 nm, where the peptide bond absorbs — records each species as a peak.

Purity is reported as the area percent of the main peak relative to total integrated peak area. A single dominant peak with minimal shouldering or secondary peaks indicates a well-resolved, homogeneous preparation. Impurities that HPLC surfaces include deletion sequences, truncations, incomplete deprotection products, oxidation variants, and residual scavengers from synthesis. Understanding the gradient, column chemistry, and detection wavelength is essential to reading a chromatogram correctly — our HPLC peptide purity testing explainer breaks down the method, the chromatogram, and common artifacts in detail.

How Peptide Identity Is Confirmed: Mass Spectrometry

HPLC tells you how pure; mass spectrometry tells you what it is. ESI-MS (electrospray ionization) or MALDI-TOF ionizes the peptide and measures its mass-to-charge ratio, allowing the observed molecular weight to be compared against the value calculated from the amino-acid sequence. A match within instrument tolerance confirms the correct primary structure and molecular formula; a mismatch flags a wrong sequence, an unexpected modification, or an adduct.

Mass spec is particularly powerful for catching problems HPLC alone can miss — for example, a co-eluting impurity of similar hydrophobicity, or a peptide that is the right length but carries an incorrect residue. For the analytical logic behind identity confirmation and how to interpret an MS spectrum on a COA, see mass spec peptide identity verification.

What "≥99% Purity" Means for Research

A ≥99% purity specification means that, by HPLC area percent, at least 99% of the detectable material is the target peptide. For research contexts this matters because impurities are not inert: deletion sequences and process contaminants can introduce confounding variables into cell-based assays, receptor-binding studies, and stability work. Lower purity widens the error bars on any result and undermines reproducibility across experiments and labs.

It is important to read the specification precisely. "≥99%" refers to chromatographic purity, not necessarily net peptide content, and the detection method and wavelength define what "purity" captures. Our deep dives on what ≥99% peptide purity means for research and the broader peptide purity standards for research use unpack these distinctions and the conventions labs rely on.

Why Third-Party Testing Matters

A COA is only as trustworthy as the party that generated it. When a supplier tests its own product and issues its own certificate, there is an inherent conflict of interest. Third-party testing — analysis by an independent laboratory with no stake in the sale — provides objective verification of identity and purity. Independent COAs, especially when tied to a specific lot number and dated, let a research buyer confirm that claims are backed by data rather than marketing.

When evaluating documentation, look for the testing lab's name, the analytical methods used, a batch or lot identifier that matches the vial you received, and raw chromatogram and spectrum images rather than a bare summary table. We cover the full rationale and red flags in why third-party peptide testing matters.

Applying This to a Real Compound

These principles are best understood against a concrete example. BPC-157 is one of the most widely studied research peptides, and its COA characterization illustrates how HPLC purity, MS identity, and independent verification come together for a single sequence. Our BPC-157 purity and third-party COA testing article walks through a representative certificate end to end.

Beyond the COA: Supplier, Shipping, and Cold-Chain Integrity

Analytical purity at the point of synthesis is necessary but not sufficient. A peptide that ships slowly or is exposed to heat can degrade before it reaches the bench, so sourcing decisions and logistics are part of the quality picture. Choosing a supplier that publishes lot-specific COAs, maintains consistent standards, and ships from the USA reduces both quality and delivery risk — see choosing a research peptide supplier (USA).

Transit conditions matter too. Same-day USA shipping for research peptides shortens the window in which a preparation sits in transit, and cold-chain shipping and peptide integrity explains how temperature control preserves lyophilized and reconstituted material. In the laboratory, most lyophilized research peptides are stored desiccated and frozen, protected from light, and reconstituted with an appropriate diluent only when needed — proper handling protects the very purity the COA documents.

Putting It Together

Rigorous peptide COA purity testing is a system, not a single number. HPLC establishes chromatographic purity, mass spectrometry confirms identity, net peptide content clarifies how much active material is present, and independent third-party analysis removes the conflict of interest from the whole chain. For laboratories, insisting on lot-matched documentation and controlled handling is the most direct route to reproducible, defensible research data. Use the cluster guides linked throughout this hub to go deeper on each analytical method and quality practice.